Приказ основних података о документу

dc.creatorBonda, David J.
dc.creatorBajić, Vladan
dc.creatorPotparević, Biljana
dc.creatorCasadesus, G.
dc.creatorZhu, Xiongwei
dc.creatorSmith, Mark A.
dc.creatorLee, Hyoung-Gon
dc.date.accessioned2019-09-02T11:21:16Z
dc.date.available2019-09-02T11:21:16Z
dc.date.issued2010
dc.identifier.issn0305-1846
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1378
dc.description.abstractThe cell cycle is a highly regulated and fundamental cellular process that involves complex feedback regulation of many proteins, and any compromise to its integrity elicits dire consequences for the cell. For example, in neurodegenerative diseases such as Alzheimer disease (AD), evidence for abnormal cell cycle re-entry precedes other hallmarks of disease and as such, implicates cell cycle aberrations in the aetiology of AD. The mechanism(s) for cell cycle re-entry in AD, however, remain unclear. Current theory suggests it to be part of a combination of early events that together elicit the degenerative pathology and cognitive phenotype consistent with the disease. We propose a 'Two-Hit Hypothesis' that highlights the concerted interaction between cell cycle alterations and oxidative stress that combine to produce neurodegeneration. Here, we review the evidence implicating cell cycle mechanisms in AD and how such changes, especially in combination with oxidative stress, would lead to a cascade of events leading to disease. Based on this concept, we propose new opportunities for disease treatment.en
dc.publisherWiley, Hoboken
dc.relationNational Institutes of Health - AG028679
dc.rightsopenAccess
dc.sourceNeuropathology and Applied Neurobiology
dc.subjectAlzheimer's diseaseen
dc.subjectcell cycle re-entryen
dc.subjectmitotic insulten
dc.subjectmitotic steady stateen
dc.subjectoxidative stressen
dc.titleReview: Cell cycle aberrations and neurodegenerationen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractБонда, Давид Ј.; Лее, Хyоунг-Гон; Цасадесус, Г.; Бајић, Владан; Зху, Xионгwеи; Смитх, Марк A.; Потпаревић, Биљана;
dc.citation.volume36
dc.citation.issue2
dc.citation.spage157
dc.citation.epage163
dc.citation.other36(2): 157-163
dc.citation.rankM21
dc.identifier.wos000275919200005
dc.identifier.doi10.1111/j.1365-2990.2010.01064.x
dc.identifier.pmid20059701
dc.identifier.scopus2-s2.0-77949897817
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/289/1376.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу